| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.047 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.035 | 0.9 |